Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes

Documenti analoghi

• Efficacy and safety of nanoparticle albumin‐bound paclitaxel in taxane‐pretreated metastatic breast cancer patients
  di: Weili Xiong, et al.
  Pubblicazione: (2024)
• The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer
  di: Jia‐Yi Huang, et al.
  Pubblicazione: (2024)
• Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France
  di: Thierry Petit, et al.
  Pubblicazione: (2024)
• Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study
  di: Wen‐Jin Zhong, et al.
  Pubblicazione: (2024)
• Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors
  di: Agostina Stradella, et al.
  Pubblicazione: (2024)